Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Israel

Showing results (241-250 of 290) with videos related to

Pageof 29
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study GroupM F Avril, J Bonneterre, M Delaunay, et al.
Nanotechnology|January 6, 2015
Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shellLiron L Israel, Elena I Kovalenko, Anna A Boyko, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|May 5, 2020
Static and dynamic postural control: Comparison between community old adults and people with Parkinson's diseaseLeilane Lazarotto, Giovana Z G Bobbo, Juliana Siega, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Fotemustine plus dacarbazine for malignant melanomaM F Avril, J Bonneterre, D Cupissol, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre studyS Negrier, T Philip, G Stoter, et al.
Cancer Treatment Reports|July 1, 1976
Adriamycin in the treatment of far-advanced lung cancerE W Knight, S Lagakos, L Stolbach, et al.
Science (New York, N.Y.)|October 16, 2010
A low-magnetic-field soft gamma repeaterN Rea, P Esposito, R Turolla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II studyH von der Maase, P Geertsen, N Thatcher, et al.
Cancer Treatment Reviews|June 1, 1989
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre studyG Stoter, S D Fosså, C Rugarli, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Preoperative chemotherapy in epidermoid bronchogenic carcinomaJ F Morere, L Israel, J L Breau, et al.
Pageof 29

Showing results (241-250 of 290) with videos related to

Sort By:
Pageof 29
Cancer Chemotherapy and Pharmacology|January 1, 1990
Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma. Experience of the French Study GroupM F Avril, J Bonneterre, M Delaunay, et al.
Nanotechnology|January 6, 2015
Towards hybrid biocompatible magnetic rHuman serum albumin-based nanoparticles: use of ultra-small (CeLn)3/4+ cation-doped maghemite nanoparticles as functional shellLiron L Israel, Elena I Kovalenko, Anna A Boyko, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|May 5, 2020
Static and dynamic postural control: Comparison between community old adults and people with Parkinson's diseaseLeilane Lazarotto, Giovana Z G Bobbo, Juliana Siega, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Fotemustine plus dacarbazine for malignant melanomaM F Avril, J Bonneterre, D Cupissol, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre studyS Negrier, T Philip, G Stoter, et al.
Cancer Treatment Reports|July 1, 1976
Adriamycin in the treatment of far-advanced lung cancerE W Knight, S Lagakos, L Stolbach, et al.
Science (New York, N.Y.)|October 16, 2010
A low-magnetic-field soft gamma repeaterN Rea, P Esposito, R Turolla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II studyH von der Maase, P Geertsen, N Thatcher, et al.
Cancer Treatment Reviews|June 1, 1989
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre studyG Stoter, S D Fosså, C Rugarli, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Preoperative chemotherapy in epidermoid bronchogenic carcinomaJ F Morere, L Israel, J L Breau, et al.
Pageof 29